Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2009

Open Access 01-12-2009 | Research

The role of disclosure in relation to assent to participate in HIV-related research among HIV-infected youth: a formative study

Authors: Amy Corneli, Lara Vaz, Jennyfer Dulyx, Serge Omba, Stuart Rennie, Frieda Behets

Published in: Journal of the International AIDS Society | Issue 1/2009

Login to get access

Abstract

Background

The objective of this study was to develop a culturally appropriate approach for obtaining assent from children aged eight to 17 years to participate in paediatric HIV-related operational research in Kinshasa, Democratic Republic of Congo (DRC). Included within this objective was to determine whether or not HIV disclosure should be included as part of the assent process prior to research participation, a component of research participation, or not incorporated in any aspect of the child's involvement in the research. Factors that influence parents' and caregivers' decisions to disclose HIV status to children in non-research contexts were also explored.

Methods

A qualitative formative study was conducted. Semi-structured interviews were conducted with 19 youth living with HIV, 36 parents and caregivers of youth living with HIV, and 17 health professionals who provide care and support to youth living with HIV and their families. Participants were purposefully selected from three HIV care, treatment and/or psychosocial support programmes in Kinshasa, DRC.

Results

Most youth interviewed believed minors participating in HIV-related research should be informed of their HIV-positive status. Parents and caregivers and health professionals had varied perspectives on if and when HIV status should be disclosed to minors during research participation. The age of the youth influenced parents and caregivers' responses, and disclosure to adolescents was more frequently supported than disclosure to children.
Several parents and caregivers, as well as some health professionals, suggested that minors should never be told their HIV-positive status when participating in HIV-related research, regardless of their age. Within the context of treatment programmes, disclosure of HIV status to minors was supported by youth, parents and caregivers, and health professionals as a means to improve adherence to medication.

Conclusion

In settings where most minors are unaware of their HIV infection, researchers should consider excluding the term, "HIV", when explaining HIV-related research to minors, and omitting it from assent forms or informational sheets related to research participation. However, an individualized disclosure plan should be initiated with parents and caregivers at the time of enrolment in HIV-related research, particularly in research that involves treatment.
Literature
1.
go back to reference American Academy of Pediatrics. Committee on Pediatric AIDS: Disclosure of Illness Status to Children and Adolescents with HIV Infection. Pediatrics 1999, 103: 164–166.CrossRef American Academy of Pediatrics. Committee on Pediatric AIDS: Disclosure of Illness Status to Children and Adolescents with HIV Infection. Pediatrics 1999, 103: 164–166.CrossRef
3.
go back to reference Barfield RC, Kane JR: Balancing disclosure of diagnosis and assent for research in children with HIV. JAMA 2008, 300: 576–578.CrossRefPubMed Barfield RC, Kane JR: Balancing disclosure of diagnosis and assent for research in children with HIV. JAMA 2008, 300: 576–578.CrossRefPubMed
4.
go back to reference Bartholome CA: Decision making in health care: youthful perspectives. Bioethics Forum 1995, 11: 35–7.PubMed Bartholome CA: Decision making in health care: youthful perspectives. Bioethics Forum 1995, 11: 35–7.PubMed
5.
go back to reference DeMatteo D, Roberts J: Disclosing HIV/AIDS to Children: The Paths We Take. Calgary, Alberta, Canada: Detselig Enterprises LTD; 2001. DeMatteo D, Roberts J: Disclosing HIV/AIDS to Children: The Paths We Take. Calgary, Alberta, Canada: Detselig Enterprises LTD; 2001.
6.
go back to reference Wiener LS, Battles HB, Heilman N, Sigelman CK, Pizzo PA: Factors associated with disclosure of diagnosis to children with HIV/AIDS. Pediatr AIDS HIV Infect 1996, 7: 310–324.PubMed Wiener LS, Battles HB, Heilman N, Sigelman CK, Pizzo PA: Factors associated with disclosure of diagnosis to children with HIV/AIDS. Pediatr AIDS HIV Infect 1996, 7: 310–324.PubMed
7.
go back to reference Wiener LS, Battles HB, Heilman NE: Factors associated with parents' decision to disclose their HIV diagnosis to their children. Child Welfare 1998, 77: 115–135.PubMed Wiener LS, Battles HB, Heilman NE: Factors associated with parents' decision to disclose their HIV diagnosis to their children. Child Welfare 1998, 77: 115–135.PubMed
8.
go back to reference Geller G, Tambor ES, Bernhardt BA, Fraser G, Wissow LS: Informed consent for enrolling minors in genetic susceptibility research: a qualitative study of at-risk children's and parents' views about children's role in decision making. Journal of Adolescent Health 2003, 32: 260–271.CrossRefPubMed Geller G, Tambor ES, Bernhardt BA, Fraser G, Wissow LS: Informed consent for enrolling minors in genetic susceptibility research: a qualitative study of at-risk children's and parents' views about children's role in decision making. Journal of Adolescent Health 2003, 32: 260–271.CrossRefPubMed
9.
go back to reference Vaz LME, Corneli AL, Dulyx J, Rennie S, Omba S, Kitetele F, the AD Research Group, Behets F: The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. AIDS Care 2008, 20 (7) : 842–52.CrossRefPubMed Vaz LME, Corneli AL, Dulyx J, Rennie S, Omba S, Kitetele F, the AD Research Group, Behets F: The process of HIV status disclosure to HIV-positive youth in Kinshasa, Democratic Republic of the Congo. AIDS Care 2008, 20 (7) : 842–52.CrossRefPubMed
10.
go back to reference Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, Malamba S, Bunnell R: Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS and Behavior 2006, 10 (4 Suppl) : S85–93.CrossRefPubMed Bikaako-Kajura W, Luyirika E, Purcell DW, Downing J, Kaharuza F, Mermin J, Malamba S, Bunnell R: Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS and Behavior 2006, 10 (4 Suppl) : S85–93.CrossRefPubMed
Metadata
Title
The role of disclosure in relation to assent to participate in HIV-related research among HIV-infected youth: a formative study
Authors
Amy Corneli
Lara Vaz
Jennyfer Dulyx
Serge Omba
Stuart Rennie
Frieda Behets
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2009
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-12-17

Other articles of this Issue 1/2009

Journal of the International AIDS Society 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.